Connect with us

Business

Apollo Proton Cancer Centre announces availability of Proton Therapy

Published

on

Dr.Sapna Nangia, Senior Consultant Radiation Oncology Apollo Proton Cancer Centre

India’s Apollo Proton Cancer Centre on Friday announced the availability of Proton Therapy treatment for Sri Lanka-based patients at its state-of-the-art facility in Chennai.During a press conference held at the Hilton Colombo Residences in Colombo, representatives of Apollo Proton Cancer Centre (APCC) – the first and only Proton Therapy Centre in South Asia and the Middle East – shed lights on the importance of Proton Therapy for improving outcomes of cancer treatment and quality survivorship.

APCC, India’s first JCI accredited Cancer hospital, also revealed that the facility had recently performed a complex treatment on Sri Lankan male for a rare form of liver cancer.

It was revealed that the Sri Lankan patient, Jayantha Pushpa Kumara Gamage, a 65-year-old, was treated with intensity-modulated proton beam therapy (IMPT) for Recurrent Oligometastatic Hepatocellular Carcinoma, at the Apollo Proton Cancer Centre (APCC) in Chennai, India, the most advanced Cancer Centre and the first Proton Therapy Centre in South Asia & the Middle East.

Gamage was diagnosed with recurrent oligometastatic hepatocellular carcinoma in the retroperitoneal region. After failed treatments with TACE, Lenvatinib, and Regorafenib, he was referred to APCC for proton therapy. Post a detailed preplanning audit, intensity-modulated proton therapy was advice and implemented successfully.

Dr Sapna Nangia, Senior Consultant, Radiation Oncology, Apollo Proton Cancer Centre, said, “I’ve seen significant advantages of proton beam therapy over traditional radiation treatments at Apollo Proton Cancer Center. By precisely targeting tumours with a focused beam of high-energy protons, we can spare healthy surrounding tissues and minimize the risk of collateral damage, particularly in vital organs and sensitive areas. This approach can translate to improved outcomes for patients, including better cancer control rates, reduced risk of side effects, and overall enhanced quality of life.”

On being treated at APCC, Gamage said, “Going through cancer treatment is never easy, but thanks to the incredible team at Apollo Proton Cancer Centre, I feel like I have my life back. After failed treatments, proton therapy was my last hope, and it worked wonders for me. The staff was incredibly kind and supportive throughout the process, and I can’t thank the team of experts and other members of the team for their dedication and expertise. I’m so grateful to be able to live my life again with minimal symptoms, and I’m excited to see what the future holds.”

The major advantage of proton therapy treatment is that protons slowly deposit their energy as they travel towards the cancerous tumour and deposit most of the radiation dose directly into the tumour without damaging the body further thus maintaining healthy tissues and organs without any complications. Proton therapy has been shown to have excellent local control of various cancers located in some of the most difficult areas such as skull-base regions of the body which are otherwise difficult to treat. The latest breakthroughs in this technology including pencil beam scanning, highly precise image guidance and tremendous refinements in the machine set-up, have led to the adoption of this technology throughout the world in hospital settings.

Proton therapy is being encouragingly adopted for the treatment of various cancers such as brain and spine tumours, skull base tumours, oral cancers, gastro-intestinal cancers, bone and soft tissue tumours, breast cancers, thoracic cancers (lung cancer), genitourinary cancers (prostate cancer) and predominantly in paediatric cancers except for leukaemia.

APCC boasts a state-of-the-art Cancer Surgery Unit that provides specialized 360-degree care using the latest technology systems for complex surgeries. With an unwavering commitment to ensuring an exceptional patient experience, the centre leverages cutting-edge treatment options to deliver world-class care.

The centre is dedicated to improving patient outcomes through research, innovation, and collaboration with other leading cancer institutions around the world. Patients receive high-quality, compassionate care in a supportive and healing environment, making the APCC a premier destination for cancer treatment.

APCC’s cancer management teams (CMT) are formed by highly skilled professionals and each CMT is focused on delivering the best possible outcomes for its patients. An added feather in the cap is the recent launch of India’s first & only site-specific Robotic Oncology Program.



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

‘Trailblazing moment’ for New Zealand-SL bilateral economic ties

Published

on

New Zealand H.C. David Pine

The landmark announcement of JAT Holdings’ acquisition of Mirotone (NZ) Ltd, New Zealand’s No. 1 industrial wood-coatings company, took place on Nov. 4th at ITC Ratnadipa, drawing leading diplomats, business leaders and industry stakeholders. The event was seen as a “trailblazing moment” for New Zealand- Sri Lanka bilateral economic ties by New Zealand’s High Commissioner to Sri Lanka David Pine.

New Zealand’s High Commissioner Pine, delivering the keynote remarks, went on to describe the acquisition as “a powerful example of responsible foreign investment; strengthening a proud New Zealand brand.”

“What we really want to see a lot more of in New Zealand—just like every other country—is high-quality foreign investment, Pine said. “And just as important is ensuring companies that have done well for decades find responsible new owners, especially after challenging periods.”

He said the acquisition was “preserving and strengthening a New Zealand company that deserved a secure future” and added:

“This is the most significant investment to date by a Sri Lankan company in New Zealand. I hope we will look back on this night—and on you, Aelian, and your team—as trailblazers.”

Aelian Gunawardene, Founder and Managing Director of JAT Holdings, said that throughout his travels across Asia and Australia, one brand consistently stood out—Mirotone, seen as a respected and dominant name in Australia, New Zealand, Malaysia, Singapore and beyond.

“For nine decades, this company led the wood-coating industry in the Asia-Pacific region, he said. “It was a brand I admired, benchmarked and looked up to. Today, to be its custodian feels almost unreal.”

He recalled the intense negotiations—early morning calls, late-night meetings, and the JAT board’s approval of a USD 3 billion allocation to acquire a top-tier international coatings brand.

“This isn’t just about growth, Gunawardene added. “It’s about joining hands with a 90-year-old legacy of craftsmanship and innovation.”

He expressed gratitude to the original founders and said JAT looked forward to celebrating the brand’s 100th anniversary in 2035.

JAT Holdings CEO Nishal Ferdinando walked stakeholders through the strategic transformation the acquisition will unlock over the next 24–30 months.

He emphasised JAT’s groundbreaking R&D capabilities, including South Asia’s first water-based wood-coating binder, developed by only four companies globally.

By Ifham Nizam

Continue Reading

Business

Sampath Bank and Ideal Motors partner to drive affordable vehicle ownership in Sri Lanka

Published

on

Kasun Fernando, General Manager – Ideal Motors (Pvt) Ltd (fourth from left), and Deepal De Silva, Chief Operating Officer – Sampath Bank (fifth from right), exchange the MoU in the presence of officials from both organisations

Sampath Bank PLC recently signed a Memorandum of Understanding (MOU) with Ideal Motors (Pvt) Ltd., an authorised distributor of Mahindra vehicles in Sri Lanka. The partnership aims to offer customers enhanced vehicle financing solutions and exclusive benefits that make vehicle ownership more affordable and convenient.

Through this collaboration, Sampath Bank will extend a range of financial privileges to customers purchasing Mahindra vehicles from Ideal Motors. These include a 0.5% per annum reduction in the published leasing interest rates, loans to cover vehicle insurance premiums with no interest if settled within two months, and Sampath Credit Cards with no joining fee, enabling customers to pay their insurance premiums at 0% interest for up to 12 months.

Commenting on the partnership, Deepal De Silva, Chief Operating Officer, Sampath Bank PLC, said, “This partnership represents our commitment to delivering practical financial solutions that support our customers’ lifestyle aspirations. The collaboration with Ideal Motors enables us to offer more accessible financing and flexible repayment options, empowering individuals and businesses to make confident vehicle ownership decisions. It also reflects our broader vision of being a trusted financial partner that continuously anticipates and responds to customer needs.”

Expressing her thoughts on the partnership, Ms. Nimisha Welgama, Director – Legal and Corporate Affairs, Ideal Motors (Pvt) Ltd., said, “We are pleased to collaborate with Sampath Bank to offer customers a selection of Mahindra vehicles complemented by attractive financing options, enhancing both value and the overall ownership experience.”

Continue Reading

Business

Positive corporate earnings driving CSE’s bull-run; ASPI hits 23,000 points

Published

on

The CSE kicked off on a bullish note yesterday because the All Share Price Index topped the 23000 points level mainly due to positive corporate earnings amid conducive macroeconomic conditions in the county.

The All Share Price Index went up by 158.99 points while the S and P SL20 rose by 57.10 points.

Turnover stood at Rs 6 billion with ten crossings. Top seven crossings were reported in Laugfs Gas where 3.95 million shares crossed for Rs 276.7 million; its shares traded at Rs 67.50, Hemas Holdings 4.9 million shares crossed for Rs 172 million; its shares traded at Rs 31, JKH 7.75 million shares crossed for Rs 168.5 million; its shares traded at Rs 20.90, NTB 450,000 shares crossed for Rs 135 million; its shares sold at Rs 300, People’s Leasing and Finance 2 million shares crossed for Rs 58 million; its shares traded at Rs 29, Commercial Bank 200,000 shares crossed for Rs 41.6 million; its shares sold at Rs 208 and HNB 90000 shares crossed for Rs 35.8 million; its shares fetched Rs 396.

In the retail market top seven companies that mainly contributed to the turnover were; Colombo Dockyard Rs 451.3 million (one million shares traded), Laugfs Gas 304 million (4.5 million shares traded), JKH Rs 260 million (11.97 million shares traded), Sierra Cables 231 million (7.6 million shares traded), Sunshine Holdings Rs 231 million (5.6 million shares traded), NDB Rs 203 million (1.4 million shares traded) and Digital Mobility Solutions Rs 196 million (1.2 million shares traded). During the day 187 million share volumes changed hands in 43220 transactions.

It is said that the banking and finance sector performed well, especially NTB, while the manufacturing sector also performed well, especially JKH, Hemas and several other companies. IT sector also performed well.

Yesterday the rupee was trading weaker at Rs 304.80/305.00 to the US dollar in the spot market from 304.55/80 on Tuesday, dealers said, while bond yields dropped by about 3-4 basis points.

By Hiran H Senewiratne

Continue Reading

Trending